Tilray Forms Strategic Alliance With Leading Pharmaceutical Company In Canada

Agreement represents major milestone recognizing medical cannabis as a conventional medicine for patients in need

CANADA: Tilray, a federally licensed producer of medical cannabis, announced today that it has signed a binding letter of intent (LOI) to be the exclusive collaborator of a major pharmaceutical company to accelerate innovation and increase availability of high quality medical cannabis products. Through this LOI and the anticipated definitive agreements, Tilray is allied with Sandoz Read the full article…